InvestorsHub Logo

papadedavid

11/03/20 1:07 PM

#20340 RE: king koopa #20338

So bad they didn't hire your services instead of this guys...yep...they look very unprofessional.

http://www.nmsconsulting.com/

https://nmsconsulting.com/our-people/

https://nmsconsulting.com/news/

October 6, 2020
NMS Consulting Selected as Strategic Advisor to Cerebain Biotech Corp. for Acquisition Project
NMS will provide management consulting services related to the formal due diligence of the PKG operations and financials, in addition to other analyses.

RMS555

11/03/20 1:07 PM

#20341 RE: king koopa #20338

I will guarantee that the Lawyers know what is going on and how to handle things with the SEC and IR @ Cerebain has stated that its in the Lawyers hands right now.

Cerebain has kept its mouth shut for a while now, and they are not gonna screw up everything that they have worked for by letting something like that happen..... especially since there has been about 50 million more shares added in the last 2 months.

Cerebain is a keeper, and when they get current it'll be too late to see anything in this price range!

TAB78

11/03/20 1:14 PM

#20343 RE: king koopa #20338

I am not familiar with that form, they did file a form last NT 10_k in Oct 2019.

Once again CBBT is Acquiring PKG, technically it is not a merger, I do not know what forms have to filed and which ones do not.

I had questioned Alan on the form *-k a couple of months ago and he cleared that up,

A couple of things of note for you:


1 The company has a choice of releasing an 8k or a public press release. As far as SEC rules are concerned they both suffice.

2 An 8k is actually cheaper for a company to put out vs a press release. More people see a press release which is why the company spent the extra money for it

3 Finally the last press release was issued to reassure the customers of PKG that nothing would change after the completion of the acquisition. These customers do not read 8ks.

Once again thank you for your continuing interest in Cerebain Biotech Corporation and stay safe

Regards,

Alan Klitenic
Cerebain Biotech Investor Relations
888 430 2221



You can email Alan, with your concerns though, here is the email address for IR ir@cerebain.com and company email info@cerebain.com

just promise to ask him for permission to post any reply you get and please do tweak it, someone on here did that last year, wasn't cool for the rest of us. I know the board would be happy to see what you get in a response